Snabes MC - Search Results

1

Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.

Miller CE, Kim JH, Kroll R, Simon JA, Soliman AM, Thomas JW, Xu Y, Ng J, Snabes MC. Miller CE, et al. Among authors: snabes mc. Am J Obstet Gynecol. 2024 Dec;231(6):630.e1-630.e13. doi: 10.1016/j.ajog.2024.06.040. Epub 2024 Jun 30. Am J Obstet Gynecol. 2024. PMID: 38955323 Free article. Clinical Trial.

2

Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome.

Snabes MC, Ng J, Li H, Ali I, Shebley M, Schlaff WD. Snabes MC, et al. F S Rep. 2023 Feb 21;4(2):206-212. doi: 10.1016/j.xfre.2023.02.007. eCollection 2023 Jun. F S Rep. 2023. PMID: 37398623 Free PMC article.

3

Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.

Brown E, Kroll R, Li H, Ng J, Pinsky B, Rodriguez JW, Thomas J, Snabes MC. Brown E, et al. Among authors: snabes mc. Obstet Gynecol. 2023 Nov 1;142(5):1068-1076. doi: 10.1097/AOG.0000000000005380. Epub 2023 Sep 28. Obstet Gynecol. 2023. PMID: 37769311 Clinical Trial.

4

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.

Simon JA, Stewart EA, Jewell S, Li M, Snabes MC. Simon JA, et al. Among authors: snabes mc. F S Rep. 2024 Jun 14;5(3):285-295. doi: 10.1016/j.xfre.2024.06.002. eCollection 2024 Sep. F S Rep. 2024. PMID: 39381651 Free PMC article.

5

Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.

Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM Jr. Bhasin S, et al. Among authors: snabes mc. JAMA Netw Open. 2023 Dec 1;6(12):e2348692. doi: 10.1001/jamanetworkopen.2023.48692. JAMA Netw Open. 2023. PMID: 38150256 Free PMC article. Clinical Trial.

6

Cardiovascular Safety of Testosterone-Replacement Therapy.

Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Lincoff AM, et al. Among authors: snabes mc. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16. N Engl J Med. 2023. PMID: 37326322 Clinical Trial.

7

Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.

Bhasin S, Lincoff AM, Nissen SE, Wannemuehler K, McDonnell ME, Peters AL, Khan N, Snabes MC, Li X, Li G, Buhr K, Pencina KM, Travison TG. Bhasin S, et al. Among authors: snabes mc. JAMA Intern Med. 2024 Apr 1;184(4):353-362. doi: 10.1001/jamainternmed.2023.7862. JAMA Intern Med. 2024. PMID: 38315466

8

Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.

Chomistek AK, Phiri K, Doherty MC, Calderbank JF, Chiuve SE, McIlroy BH, Snabes MC, Enger C, Seeger JD. Chomistek AK, et al. Among authors: snabes mc. Drug Saf. 2023 Feb;46(2):209-222. doi: 10.1007/s40264-022-01261-5. Epub 2023 Jan 19. Drug Saf. 2023. PMID: 36656445 Free PMC article.

9

Correction to: Development and Validation of ICD‑10‑CM‑based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.

Chomistek AK, Phiri K, Doherty MC, Calderbank JF, Chiuve SE, McIlroy BH, Snabes MC, Enger C, Seeger JD. Chomistek AK, et al. Among authors: snabes mc. Drug Saf. 2023 May;46(5):515. doi: 10.1007/s40264-023-01280-w. Drug Saf. 2023. PMID: 36964331 Free PMC article. No abstract available.

10

Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.

Abrao MS, Surrey E, Gordon K, Snabes MC, Wang H, Ijacu H, Taylor HS. Abrao MS, et al. Among authors: snabes mc. BMC Womens Health. 2021 Jun 16;21(1):246. doi: 10.1186/s12905-021-01385-3. BMC Womens Health. 2021. PMID: 34134684 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters